The conference aims at bringing together international experts from
different fields of cancer research to present and discuss new therapeutic approaches regarding different...
The conference aims at bringing together international experts from
different fields of cancer research to present and discuss new therapeutic approaches regarding different tumor entities as well as new findings in the field of tumor biology seeking to incorporate innovative platforms into cancer research.
Not exact matches
«This study not only represents a longstanding collaboration between the University
of Utah and UCSF but also is a reflection
of the transition in research from single investigators working on their own to highly collaborative studies with experts in many
fields from
different institutions,» says Mulvihill, who is also a pancreatic
cancer surgeon and an investigator with the University of Utah's Huntsman Cancer Inst
cancer surgeon and an investigator with the University
of Utah's Huntsman
Cancer Inst
Cancer Institute.
A similar principle is used in the medical
field to detect biomarkers for
different kinds
of health conditions, including
cancer, by taking breath samples.
While the main focus
of this Society is not related to
cancer genomic medicine, the conveners
of the meeting had hoped that this invited keynote from a completely
different field would guide and inspire their members into thinking
of their own research that will one day personalize patient care in their specialty.
This is why recent work in the
field of cancer research has focused on picking apart the complex cellular pathways involved in the development
of different cancers and identifying the roles
of key proteins involved, with the goal
of being able to discriminately and effectively eliminate cancerous cells from the body.
The Institut de Pathologie de Paris (France) is an organization dedicated to anatomic pathology, a key specialty
field in the battle against
different types
of cancer.
Ultimately the results will help the
field of cancer research to learn how to combine and develop
different therapies to achieve better clinical outcomes for leukaemia patients.
Dr. Carey is a nationally - recognized leader in the
field of clinical / translational research in breast
cancer, with a particular interest in the clinical implications
of different molecular subtypes
of breast
cancer.
Health information technology is a broad
field that encompasses a number
of different occupations, including clinical informatics, programming,
cancer registrars and medical record and health information technicians.